Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nasal inhalation of isopropyl alcohol to treat nausea in patients with cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isopropyl alcohol (isopropyl alcohol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Neoplasm | Phase 2 | Status: NOT_YET_RECRUITING